Scarica l'app Stockscreener
2.79
3.33%
0.09
Pre-mercato:
2.79
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché GDRX Giù?
Forum
Previsione
Precedente Chiudi:
$2.70
Aprire:
$2.69
Volume 24 ore:
1.20M
Relative Volume:
0.34
Capitalizzazione di mercato:
$947.02M
Reddito:
$775.09M
Utile/perdita netta:
$-58.68M
Rapporto P/E:
-21.04
EPS:
-0.1326
Flusso di cassa netto:
$64.06M
1 W Prestazione:
+1.82%
1M Prestazione:
-8.82%
6M Prestazione:
-38.55%
1 anno Prestazione:
-43.29%
Intervallo 1D:
$2.68
$2.82
Intervallo di 1 settimana:
$2.615
$2.82
Portata 52W:
$2.61
$5.8099
Goodrx Holdings Inc Stock (GDRX) Company Profile
Nome
Goodrx Holdings Inc
Settore
Industria
Telefono
(855) 268-2822
Indirizzo
2701 OLYMPIC BOULEVARD, SANTA MONICA
Confronta GDRX con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
GDRX
Goodrx Holdings Inc
|
2.79 | 916.47M | 775.09M | -58.68M | 64.06M | -0.1326 |
|
VEEV
Veeva Systems Inc
|
229.16 | 38.14B | 3.08B | 860.33M | 1.35B | 5.1463 |
|
TEM
Tempus Ai Inc
|
75.07 | 13.50B | 803.32M | -709.10M | -212.68M | -7.8003 |
|
DOCS
Doximity Inc
|
45.04 | 8.50B | 550.17M | 201.35M | 232.07M | 1.00 |
|
HQY
Healthequity Inc
|
95.73 | 7.97B | 1.15B | 96.70M | -161.99M | 1.09 |
|
BTSG
Brightspring Health Services Inc
|
35.20 | 6.39B | 11.99B | 24.18M | 234.31M | 0.2956 |
Goodrx Holdings Inc Stock (GDRX) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-12-09 | Iniziato | Barclays | Underweight |
| 2025-08-11 | Downgrade | Raymond James | Strong Buy → Outperform |
| 2024-12-04 | Iniziato | Mizuho | Neutral |
| 2024-08-09 | Aggiornamento | Raymond James | Outperform → Strong Buy |
| 2024-05-23 | Aggiornamento | RBC Capital Mkts | Sector Perform → Outperform |
| 2024-05-16 | Aggiornamento | Raymond James | Mkt Perform → Outperform |
| 2024-04-10 | Aggiornamento | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2024-03-25 | Aggiornamento | Wells Fargo | Equal Weight → Overweight |
| 2024-03-01 | Aggiornamento | JP Morgan | Neutral → Overweight |
| 2024-02-26 | Iniziato | Leerink Partners | Outperform |
| 2024-01-02 | Downgrade | BofA Securities | Buy → Underperform |
| 2023-08-10 | Aggiornamento | DA Davidson | Neutral → Buy |
| 2023-07-31 | Aggiornamento | TD Cowen | Market Perform → Outperform |
| 2022-12-01 | Iniziato | Citigroup | Buy |
| 2022-11-04 | Aggiornamento | JP Morgan | Underweight → Neutral |
| 2022-09-16 | Iniziato | KeyBanc Capital Markets | Sector Weight |
| 2022-09-07 | Iniziato | Truist | Hold |
| 2022-08-12 | Iniziato | DA Davidson | Neutral |
| 2022-06-10 | Downgrade | Goldman | Buy → Neutral |
| 2022-06-06 | Ripresa | BofA Securities | Buy |
| 2022-06-01 | Downgrade | Robert W. Baird | Outperform → Neutral |
| 2022-05-10 | Downgrade | Evercore ISI | Outperform → In-line |
| 2022-05-10 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| 2022-05-10 | Downgrade | Raymond James | Outperform → Mkt Perform |
| 2022-05-10 | Downgrade | SVB Leerink | Outperform → Mkt Perform |
| 2022-04-11 | Iniziato | Wells Fargo | Equal Weight |
| 2022-04-07 | Iniziato | Guggenheim | Buy |
| 2022-04-01 | Ripresa | Credit Suisse | Neutral |
| 2022-03-15 | Aggiornamento | Robert W. Baird | Neutral → Outperform |
| 2022-03-01 | Reiterato | Barclays | Overweight |
| 2022-03-01 | Reiterato | BofA Securities | Neutral |
| 2022-03-01 | Downgrade | Cowen | Outperform → Market Perform |
| 2022-03-01 | Downgrade | Credit Suisse | Outperform → Neutral |
| 2022-03-01 | Reiterato | Evercore ISI | Outperform |
| 2022-03-01 | Reiterato | Goldman | Buy |
| 2022-03-01 | Reiterato | JP Morgan | Underweight |
| 2022-03-01 | Reiterato | RBC Capital Mkts | Outperform |
| 2022-03-01 | Reiterato | SVB Leerink | Outperform |
| 2022-01-07 | Iniziato | Goldman | Buy |
| 2021-12-21 | Iniziato | Stephens | Overweight |
| 2021-12-02 | Iniziato | Jefferies | Buy |
| 2021-08-31 | Aggiornamento | Barclays | Equal Weight → Overweight |
| 2021-08-13 | Aggiornamento | Raymond James | Mkt Perform → Outperform |
| 2021-05-28 | Iniziato | Robert W. Baird | Neutral |
| 2021-04-06 | Ripresa | Evercore ISI | Outperform |
| 2021-01-25 | Iniziato | Guggenheim | Buy |
| 2020-11-19 | Aggiornamento | RBC Capital Mkts | Sector Perform → Outperform |
| 2020-11-18 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2020-10-19 | Iniziato | Barclays | Equal Weight |
| 2020-10-19 | Iniziato | BofA Securities | Neutral |
| 2020-10-19 | Iniziato | Citigroup | Buy |
| 2020-10-19 | Iniziato | Cowen | Outperform |
| 2020-10-19 | Iniziato | Credit Suisse | Outperform |
| 2020-10-19 | Iniziato | Deutsche Bank | Hold |
| 2020-10-19 | Iniziato | Goldman | Neutral |
| 2020-10-19 | Iniziato | JP Morgan | Neutral |
| 2020-10-19 | Iniziato | Morgan Stanley | Overweight |
| 2020-10-19 | Iniziato | RBC Capital Mkts | Sector Perform |
| 2020-10-19 | Iniziato | SVB Leerink | Outperform |
| 2020-10-19 | Iniziato | UBS | Buy |
Mostra tutto
Goodrx Holdings Inc Borsa (GDRX) Ultime notizie
Barclays Initiates Coverage of GoodRx Holdings (GDRX) with Underweight Recommendation - Nasdaq
Why GoodRx (GDRX) Stock Is Trading Lower Today - Markets Financial Content
Barclays Initiates Coverage on GoodRx Holdings (GDRX) with Under - GuruFocus
What does Wall Street think about GoodRx Holdings (GDRX)? - MSN
What Does Wall Street Think About GoodRx Holdings (GDRX)? - Insider Monkey
Is GoodRx Holdings Inc a good long term investmentRelative Strength Index (RSI) & Free Tremendous Growth Opportunities - earlytimes.in
9 Best Affordable Stocks Under $5 to Buy for the Next 3 Years - Insider Monkey
Will GoodRx Holdings Inc. stock outperform value stocksJuly 2025 Market Mood & Risk Managed Investment Strategies - Newser
Why The Narrative Around GoodRx Is Shifting Amid New Partnerships And Industry Uncertainty - Yahoo Finance
Declining Stock and Decent Financials: Is The Market Wrong About GoodRx Holdings, Inc. (NASDAQ:GDRX)? - 富途牛牛
Will GoodRx Holdings Inc. stock deliver long term returnsPortfolio Profit Report & Community Supported Trade Ideas - Newser
GoodRx Holdings (GDRX) Stock Analysis Report | Ratings, Financials & Performance - Benzinga
XTX Topco Ltd Boosts Stake in GoodRx Holdings, Inc. $GDRX - MarketBeat
HIMS vs. GDRX: Which Consumer Health Stock Offers Greater Upside? - sharewise.com
Analyst Upgrade: Can GoodRx Holdings Inc. stock attract ESG capital inflowsWeekly Risk Report & Real-Time Volume Trigger Notifications - moha.gov.vn
Will GoodRx Holdings Inc. stock benefit from commodity pricesJuly 2025 Update & Reliable Entry Point Trade Alerts - BỘ NỘI VỤ
GoodRx Holdings And 2 Other Promising Penny Stocks - Yahoo Finance
GoodRx Earnings Call: Growth Amid Challenges - MSN
LSV Asset Management Takes Position in GoodRx Holdings, Inc. $GDRX - MarketBeat
How strong is GoodRx Holdings Inc. stock revenue growthTrade Risk Report & AI Enhanced Trade Execution Alerts - newser.com
Can GoodRx Holdings Inc. stock double in next 5 yearsJuly 2025 Market Mood & Stepwise Swing Trade Plans - newser.com
Real time breakdown of GoodRx Holdings Inc. stock performanceJuly 2025 Snapshot & AI Forecasted Stock Moves - newser.com
How GoodRx Holdings Inc. stock performs after earningsM&A Rumor & Safe Entry Trade Reports - newser.com
Detecting price anomalies in GoodRx Holdings Inc. with AITrade Volume Report & Free Technical Confirmation Trade Alerts - newser.com
Risk adjusted return profile for GoodRx Holdings Inc. analyzedWeekly Trade Review & Free Fast Entry Momentum Trade Alerts - newser.com
Ranking GoodRx Holdings Inc. among high performing stocks via toolsTrade Risk Summary & Consistent Return Strategy Ideas - newser.com
How the Story Around GoodRx Is Shifting as Analyst Sentiment and Partnerships Evolve - Yahoo Finance
Smart tools for monitoring GoodRx Holdings Inc.’s price action2025 Retail Activity & Verified Entry Point Signals - newser.com
GoodRx (NASDAQ:GDRX) Sets New 1-Year LowWhat's Next? - MarketBeat
GoodRx Holdings, Inc.Class A Common Stock (NQ: GDRX - FinancialContent
GoodRx stock falls as BofA lowers price target on weight loss initiatives By Investing.com - Investing.com South Africa
GoodRx Holdings Inc. (GDRX) PT Lowered to $3 at BofA Securities - StreetInsider
GoodRx stock falls as BofA lowers price target on weight loss initiatives - Investing.com Nigeria
[Form 4] GoodRx Holdings, Inc. Insider Trading Activity - Stock Titan
Officer Nabiey Acquires 3,085 Of GoodRx Holdings Inc [GDRX] - TradingView
Goodrx stock hits 52-week low at 2.94 USD By Investing.com - Investing.com Nigeria
Novo Nordisk Leans Into Affordability Amid Rising Competition - Benzinga
GoodRx (GDRX) Expands Access to GLP-1 Medications with New Initiatives - GuruFocus
Goodrx stock hits 52-week low at 2.94 USD - Investing.com
GoodRx stock ticks up after launching weight loss subscription service By Investing.com - Investing.com Nigeria
GoodRx stock ticks up after launching weight loss subscription service - Investing.com India
GoodRx (Nasdaq: GDRX) unveils $199 Ozempic, Wegovy and $39 GLP-1 plan subscription - Stock Titan
Using Ichimoku Cloud for GoodRx Holdings Inc. technicalsSell Signal & High Win Rate Trade Tips - newser.com
Measuring GoodRx Holdings Inc.’s beta against major indicesRate Hike & Weekly Setup with ROI Potential - newser.com
Real time social sentiment graph for GoodRx Holdings Inc.July 2025 Macro Moves & Entry and Exit Point Strategies - newser.com
Is GoodRx Holdings Inc. meeting your algorithmic filter criteriaPortfolio Performance Summary & AI Based Buy/Sell Signal Reports - newser.com
Goodrx Holdings Inc Azioni (GDRX) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.74%
4.47%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):